blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1585515

EP1585515 - PIPERIDINE AND PYRROLIDINE DERIVATIVES AS ANTAGONISTS OF HISTAMINE H3 RECEPTOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.07.2010
Database last updated on 19.10.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): TR		published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
High Point Pharmaceuticals, LLC
4170 Mendenhall Oaks Parkway
High Point, NC 27265 / US
[2009/10]
Former [2008/37]For all designated states
TransTech Pharma, Inc
4170 Mendenhall Oaks Pkwy
High Point NC 27265 / US
Former [2005/42]For all designated states
NOVO NORDISK A/S
Novo Allé
2880 Bagsvaerd / DK
Inventor(s)01 / SORENSEN, Jan, Lindy
Munkehojvange 20
DK-3520 Farum / DK
02 / ANDERSEN, Knud, Erik
Hvedemarksvej 10
DK-2605 Brondby / DK
03 / PETTERSSON, Ingrid
Grundtvigsvej 18, 2th
S-1864 Frederiksberg / DK
 [2005/42]
Representative(s)Russell, Lindsey, et al
Elkington and Fife LLP
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
[N/P]
Former [2009/45]Bailey, Lindsey, et al
Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus
London EC1N 2HA / GB
Former [2008/39]Bailey, Lindsey, et al
Elkington and Fife LLP Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
Former [2005/42]Noergaard, Torsten
c/o Novo Nordisk A/S Novo Allé
2880 Bagsvaerd / DK
Application number, filing date03779754.518.12.2003
[2005/42]
WO2003DK00897
Priority number, dateDK2002000193218.12.2002         Original published format: DK 200201932
DK2003000048431.03.2003         Original published format: DK 200300484
[2005/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004054973
Date:01.07.2004
Language:EN
[2004/27]
Type: A2 Application without search report 
No.:EP1585515
Date:19.10.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 01.07.2004 takes the place of the publication of the European patent application.
[2005/42]
Type: B1 Patent specification 
No.:EP1585515
Date:16.09.2009
Language:EN
[2009/38]
Search report(s)International search report - published on:EP19.08.2004
ClassificationIPC:A61K31/40
[2005/42]
CPC:
C07D401/04 (EP,US); A61P1/04 (EP); A61P1/14 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P27/16 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P37/08 (EP);
A61P43/00 (EP); C07D413/04 (EP,US); C07D413/06 (EP,US);
C07D413/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/42]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:PIPERIDIN- UND PYRROLIDIN-DERIVATE ALSANTAGONISTEN DES HISTAMIN-H3-REZEPTORS[2005/42]
English:PIPERIDINE AND PYRROLIDINE DERIVATIVES AS ANTAGONISTS OF HISTAMINE H3 RECEPTOR[2005/42]
French:DERIVES D'HOMOPIPERDINE, DE PIPERIDINE OU DE PYRROLIDINE SUBSTITUES[2005/42]
Entry into regional phase18.07.2005National basic fee paid 
18.07.2005Designation fee(s) paid 
18.07.2005Examination fee paid 
Examination procedure21.06.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.07.2005Examination requested  [2005/42]
23.11.2006Despatch of a communication from the examining division (Time limit: M06)
10.05.2007Reply to a communication from the examining division
12.06.2008Despatch of a communication from the examining division (Time limit: M04)
22.10.2008Reply to a communication from the examining division
25.03.2009Communication of intention to grant the patent
29.07.2009Fee for grant paid
29.07.2009Fee for publishing/printing paid
Opposition(s)17.06.2010No opposition filed within time limit [2010/34]
Fees paidRenewal fee
02.01.2006Renewal fee patent year 03
02.01.2007Renewal fee patent year 04
02.01.2008Renewal fee patent year 05
15.12.2008Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT16.09.2009
BE16.09.2009
CY16.09.2009
CZ16.09.2009
DK16.09.2009
EE16.09.2009
FI16.09.2009
IT16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
SK16.09.2009
TR16.09.2009
GR17.12.2009
LU18.12.2009
ES27.12.2009
BG31.12.2009
PT18.01.2010
HU17.03.2010
[2011/44]
Former [2011/31]AT16.09.2009
BE16.09.2009
CY16.09.2009
CZ16.09.2009
DK16.09.2009
EE16.09.2009
FI16.09.2009
IT16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
SK16.09.2009
GR17.12.2009
LU18.12.2009
ES27.12.2009
BG31.12.2009
PT18.01.2010
HU17.03.2010
Former [2011/21]AT16.09.2009
BE16.09.2009
CY16.09.2009
CZ16.09.2009
DK16.09.2009
EE16.09.2009
FI16.09.2009
IT16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
SK16.09.2009
GR17.12.2009
LU18.12.2009
ES27.12.2009
BG31.12.2009
PT18.01.2010
Former [2011/14]AT16.09.2009
BE16.09.2009
CY16.09.2009
CZ16.09.2009
DK16.09.2009
EE16.09.2009
FI16.09.2009
IT16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
SK16.09.2009
GR17.12.2009
ES27.12.2009
BG31.12.2009
PT18.01.2010
Former [2010/49]AT16.09.2009
BE16.09.2009
CY16.09.2009
CZ16.09.2009
DK16.09.2009
EE16.09.2009
FI16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
SK16.09.2009
GR17.12.2009
ES27.12.2009
PT18.01.2010
Former [2010/35]AT16.09.2009
BE16.09.2009
CY16.09.2009
CZ16.09.2009
DK16.09.2009
EE16.09.2009
FI16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
SK16.09.2009
ES27.12.2009
PT18.01.2010
Former [2010/30]AT16.09.2009
BE16.09.2009
CY16.09.2009
CZ16.09.2009
EE16.09.2009
FI16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
SK16.09.2009
ES27.12.2009
PT18.01.2010
Former [2010/28]BE16.09.2009
CY16.09.2009
CZ16.09.2009
EE16.09.2009
FI16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
SK16.09.2009
ES27.12.2009
PT18.01.2010
Former [2010/23]CY16.09.2009
CZ16.09.2009
EE16.09.2009
FI16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
SK16.09.2009
ES27.12.2009
PT18.01.2010
Former [2010/22]CY16.09.2009
CZ16.09.2009
EE16.09.2009
FI16.09.2009
NL16.09.2009
RO16.09.2009
SE16.09.2009
SI16.09.2009
ES27.12.2009
PT18.01.2010
Former [2010/20]CY16.09.2009
EE16.09.2009
FI16.09.2009
NL16.09.2009
SE16.09.2009
SI16.09.2009
ES27.12.2009
Former [2010/19]CY16.09.2009
FI16.09.2009
NL16.09.2009
SE16.09.2009
SI16.09.2009
ES27.12.2009
Former [2010/16]CY16.09.2009
FI16.09.2009
NL16.09.2009
SE16.09.2009
SI16.09.2009
Former [2010/11]FI16.09.2009
NL16.09.2009
SE16.09.2009
SI16.09.2009
Former [2010/10]FI16.09.2009
NL16.09.2009
SE16.09.2009
Former [2010/09]FI16.09.2009
SE16.09.2009
Cited inInternational search[A]WO9320061  (UNIV TOLEDO [US], et al) [A] 1-71* Formula I *;
 [A]US5633382  (DURANT GRAHAM J [US], et al) [A] 1-71 * Formula I *;
 [PA]US2003191112  (DORWALD FLORENCIO ZARAGOZA [DK]) [PA] 1-71 * claims 1-32 *;
 [E]WO03103669  (SCHERING CORP [US]) [E] 1-71 * Formula I *;
 [E]US6673829  (DORWALD FLORENCIO ZARAGOZA [DK], et al) [E] 1-71 * claims 1-28 *;
 [A]  - APELT JOACHIM ET AL, "Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.", JOURNAL OF MEDICINAL CHEMISTRY. UNITED STATES 28 FEB 2002, (20020228), vol. 45, no. 5, ISSN 0022-2623, pages 1128 - 1141, XP002280989 [A] 1-71 * Chart 2, UCL 1972, FUB 649 *

DOI:   http://dx.doi.org/10.1021/jm0110845
 [A]  - WILLIAMS J P ET AL, "A solution-phase combinatorial synthesis of selective dopamine D4 ligands.", COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING. NETHERLANDS FEB 2000, (200002), vol. 3, no. 1, ISSN 1386-2073, pages 43 - 50, XP002280990 [A] 1-71 * figure 2 *
 [PX]  - APODACA RICHARD ET AL, "A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.", JOURNAL OF MEDICINAL CHEMISTRY. UNITED STATES 28 AUG 2003, (20030828), vol. 46, no. 18, ISSN 0022-2623, pages 3938 - 3944, XP002280991 [PX] 1-71 * table 1 *

DOI:   http://dx.doi.org/10.1021/jm030185v
 [PX]  - KITBUNNADAJ RUENGWIT ET AL, "Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.", JOURNAL OF MEDICINAL CHEMISTRY. UNITED STATES 4 DEC 2003, (20031204), vol. 46, no. 25, ISSN 0022-2623, pages 5445 - 5457, XP002280992 [PX] 1-71 * Schemes 1-6 *

DOI:   http://dx.doi.org/10.1021/jm030905y
by applicantWO9313083
 WO0039125
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.